Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-08

Clinical Trial Update: Clonidine With Morphine in Patient Controlled Analgesia Pump in Vaso-Occlusive Crisis in Sickle Cell Disease Patient [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating clonidine added to morphine in a patient-controlled analgesia pump for vaso-occlusive crises in sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonidine (clonidine)
  • Morphine (morphine)

Snippet

Sponsor: Centre Hospitalier Universitaire Saint Pierre | Conditions: Sickle Cell Disease, Vaso-occlusive Pain Episode in Sickle Cell Disease | Phase 4 | Status: UNKNOWN